Pfizer Inc (PFE)
27.72
-0.22
(-0.79%)
USD |
NYSE |
Mar 18, 16:00
27.72
0.00 (0.00%)
Pre-Market: 07:56
Pfizer Gross Profit Margin (Quarterly): 46.92% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 46.92% |
September 30, 2023 | 29.95% |
June 30, 2023 | 74.58% |
March 31, 2023 | 73.27% |
December 31, 2022 | 60.28% |
September 30, 2022 | 73.22% |
June 30, 2022 | 68.83% |
March 31, 2022 | 61.09% |
December 31, 2021 | 59.16% |
September 30, 2021 | 58.68% |
June 30, 2021 | 62.98% |
March 31, 2021 | 71.36% |
December 31, 2020 | 76.28% |
September 30, 2020 | 80.47% |
June 30, 2020 | 81.49% |
March 31, 2020 | 80.76% |
December 31, 2019 | 75.96% |
September 30, 2019 | 79.48% |
June 30, 2019 | 80.58% |
March 31, 2019 | 81.45% |
December 31, 2018 | 29.52% |
September 30, 2018 | 79.74% |
June 30, 2018 | 78.35% |
March 31, 2018 | 80.14% |
December 31, 2017 | 76.24% |
Date | Value |
---|---|
September 30, 2017 | 78.40% |
June 30, 2017 | 79.37% |
March 31, 2017 | 80.69% |
December 31, 2016 | 76.44% |
September 30, 2016 | 76.35% |
June 30, 2016 | 75.86% |
March 31, 2016 | 78.08% |
December 31, 2015 | 75.72% |
September 30, 2015 | 81.64% |
June 30, 2015 | 81.61% |
March 31, 2015 | 83.08% |
December 31, 2014 | 79.40% |
September 30, 2014 | 80.84% |
June 30, 2014 | 80.72% |
March 31, 2014 | 81.99% |
December 31, 2013 | 79.39% |
September 30, 2013 | 81.91% |
June 30, 2013 | 82.72% |
March 31, 2013 | 81.76% |
December 31, 2012 | 80.18% |
September 30, 2012 | 82.17% |
June 30, 2012 | 82.99% |
March 31, 2012 | 81.56% |
December 31, 2011 | 82.79% |
September 30, 2011 | 79.48% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
29.95%
Minimum
Sep 2023
81.49%
Maximum
Jun 2020
68.84%
Average
73.25%
Median
Gross Profit Margin (Quarterly) Benchmarks
Amgen Inc | 62.03% |
Gilead Sciences Inc | 70.62% |
Johnson & Johnson | 68.23% |
Eli Lilly and Co | 80.88% |
Moderna Inc | 66.97% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 2.19% |
Return on Assets | 1.00% |
Return on Invested Capital | 1.41% |
Profit Margin (Quarterly) | -23.64% |
Operating Margin (Quarterly) | -13.83% |
Return on Net Operating Assets | 1.48% |